Inventor · disambiguated record
Huanming Chen
Also filed as: CHEN HUANMING
22 granted patents·9 pending applications·59 citations·filing 2006–2023
92Inventor score
Files withSHANGHAI ZHIMENG BIOPHARMA INC10VERNIER JEAN-MICHEL4ARDEA BIOSCIENCES INC3VALEANT PHARMACEUTICALS INT3VASUDEVAN ANIL3
Top patents by PatentIndex Score
31 records- 0188US8993593B2N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulatorsVERNIER JEAN-MICHEL·Filed 2010·Granted Mar 31, 2015·18 cites·2 claims
- 0288US8293911B2Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulatorsVERNIER JEAN-MICHEL·Filed 2007·Granted Oct 23, 2012·20 cites·13 claims
- 0387US7429667B2Phenylamino isothiazole carboxamidines as MEK inhibitorsARDEA BIOSCIENCES INC·Filed 2006·Granted Sep 30, 2008·7 cites·13 claims
- 0483US7786146B2Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulatorsVALEANT PHARMACEUTICALS INT·Filed 2008·Granted Aug 31, 2010·7 cites·15 claims
- 0583US7652047B2Phenylamino isothiazole carboxamidines as MEK inhibitorsARDEA BIOSCIENCES INC·Filed 2008·Granted Jan 26, 2010·4 cites·27 claims
- 0670US12157726B2P-phenylenediamine derivative as potassium channel regulator and preparation method and medical application thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2022·Granted Dec 3, 2024·0 cites·11 claims
- 0770US8067452B23-hydroxyisothiazole-4-carboxamidine derivatives as CHK2 inhibitorsWU JIM ZHEN·Filed 2008·Granted Nov 29, 2011·1 cites·9 claims
- 0869US7465742B2Heterocyclic compounds having anti-HBV activityCHEN HUANMING·Filed 2006·Granted Dec 16, 2008·2 cites·28 claims
- 0965US12319656B2Compound as potassium channel regulator and preparation and use thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2021·Granted Jun 3, 2025·0 cites·10 claims
- 1062US8188314B2Benzyloxy anilide derivatives useful as potassium channel modulatorsWU JIM ZHEN·Filed 2009·Granted May 29, 2012·0 cites·4 claims
- 1160US2024368143A1Crystal form of compound represented by formula i, and preparation therefor and application thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1260US2024336607A1Preparation method for hepatitis b virus nucleocapsid inhibitorSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1360US2025144115A1Amide compound as potassium channel regulator, and preparation therefor and use thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1456US7960436B2Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulatorsVALEANT PHARMACEUTICALS INT·Filed 2007·Granted Jun 14, 2011·0 cites·17 claims
- 1555US2011166123A1Novel compositions and methods of useAARDEA BIOSCIENCES INC·Filed 2009·Application pending·0 cites
- 1655US2009029983A1Novel heterocyclic compounds having anti-hbv activityVALEANT RES & DEV·Filed 2008·Application pending·0 cites
- 1754US2023077155A1Tetrahydroisoquinoline compound as potassium channel modulator and preparation and application thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1853US11365181B2P-phenylenediamine derivative as potassium channel regulator and preparation method and medical application thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2019·Granted Jun 21, 2022·0 cites·9 claims
- 1952US12473276B2Compound having neuroprotective effect, preparation method therefor and use thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2020·Granted Nov 18, 2025·0 cites·8 claims
- 2051US12492170B2Tetrahydro-1H-benzazepine compound as potassium channel modulator, preparation method and use thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2020·Granted Dec 9, 2025·0 cites·9 claims
- 2150US8492588B2Benzyloxy anilide derivatives useful as potassium channel modulatorsWU JIM ZHEN·Filed 2012·Granted Jul 23, 2013·0 cites·1 claims
- 2250US2014155389A1Bicyclic inhibitors of alkVASUDEVAN ANIL·Filed 2012·Application pending·0 cites
- 2350US2014171429A1Bicyclic inhibitors of alkVASUDEVAN ANIL·Filed 2012·Application pending·0 cites
- 2449US12486265B22-aminopyrimidine compounds and pharmaceutical compositions and uses thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2020·Granted Dec 2, 2025·0 cites·15 claims
- 2549US2011269741A1Novel compositions and methods of useARDEA BIOSCIENCES INC·Filed 2011·Application pending·0 cites
- 2648US8722929B2N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulatorsVERNIER JEAN-MICHEL·Filed 2007·Granted May 13, 2014·0 cites·6 claims
- 2747US8030518B21,4 diamino bicyclic retigabine analogues as potassium channel modulatorsVALEANT PHARMACEUTICALS INT·Filed 2007·Granted Oct 4, 2011·0 cites·38 claims
- 2844US8338487B2Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and -2,3-dihydro-1H-indenes as potassium channel modulatorsCHEN HUANMING·Filed 2011·Granted Dec 25, 2012·0 cites·20 claims
- 2944US8211918B2Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulatorsVERNIER JEAN-MICHEL·Filed 2010·Granted Jul 3, 2012·0 cites·25 claims
- 3041US10519145B2Pyrazole-oxazolidinone compound for anti-hepatitis B virusSHANGHAI ZHIMENG BIOPHARMA CO LTD·Filed 2017·Granted Dec 31, 2019·0 cites·20 claims
- 3138US9212192B2Bicyclic carboxamide inhibitors of kinasesVASUDEVAN ANIL·Filed 2012·Granted Dec 15, 2015·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →